Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hillard Lazarus

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|January 15, 2016
Cord blood transplant for acute myeloid leukaemiaKaren K Ballen, Hillard Lazarus
Bone Marrow Transplantation|May 25, 2026
Jargon reduxRobert Peter Gale, Hillard Lazarus
Hematology/Oncology and Stem Cell Therapy|September 4, 2018
Combined haploidentical and umbilical cord blood transplantation for severe aplastic anemia: Unique hematopoietic reconstitutionAnant Vatsayan, Hasan Hashem, Kristen Nagle, et al.
Blood Reviews|August 29, 2020
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?Hamdan Hamdan, Shahrukh K Hashmi, Hillard Lazarus, et al.
Leukemia & Lymphoma|February 3, 2026
ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysisJoseph O'Brien, Ben Tomlinson, Mayher J Patel, et al.
Blood Reviews|December 1, 2014
All in the family: Clueing into the link between metabolic syndrome and hematologic malignanciesReem Karmali, Andrew Dalovisio, Jeffrey A Borgia, et al.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapyDale S Adler, Hillard Lazarus, Ravi Nair, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study GroupMark S Freedman, Amit Bar-Or, Harold L Atkins, et al.
Leukemia & Lymphoma|October 6, 2007
Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemiaPaul Barr, Pingfu Fu, Hillard Lazarus, et al.
Bone Marrow Transplantation|February 7, 2020
Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administrationNaveed Ali, Brenda Cooper, Benjamin Tomlinson, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|January 15, 2016
Cord blood transplant for acute myeloid leukaemiaKaren K Ballen, Hillard Lazarus
Bone Marrow Transplantation|May 25, 2026
Jargon reduxRobert Peter Gale, Hillard Lazarus
Hematology/Oncology and Stem Cell Therapy|September 4, 2018
Combined haploidentical and umbilical cord blood transplantation for severe aplastic anemia: Unique hematopoietic reconstitutionAnant Vatsayan, Hasan Hashem, Kristen Nagle, et al.
Blood Reviews|August 29, 2020
Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?Hamdan Hamdan, Shahrukh K Hashmi, Hillard Lazarus, et al.
Leukemia & Lymphoma|February 3, 2026
ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysisJoseph O'Brien, Ben Tomlinson, Mayher J Patel, et al.
Blood Reviews|December 1, 2014
All in the family: Clueing into the link between metabolic syndrome and hematologic malignanciesReem Karmali, Andrew Dalovisio, Jeffrey A Borgia, et al.
Frontiers in Bioscience (Elite Edition)|January 4, 2011
Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapyDale S Adler, Hillard Lazarus, Ravi Nair, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study GroupMark S Freedman, Amit Bar-Or, Harold L Atkins, et al.
Leukemia & Lymphoma|October 6, 2007
Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemiaPaul Barr, Pingfu Fu, Hillard Lazarus, et al.
Bone Marrow Transplantation|February 7, 2020
Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administrationNaveed Ali, Brenda Cooper, Benjamin Tomlinson, et al.
Pageof 5